Goldman Myla Lai - 16 Sep 2021 Form 3 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Myla Lai-Goldman, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
16 Sep 2021
Net transactions value
$0
Form type
3
Filing time
20 Sep 2021, 20:48:46 UTC
Next filing
26 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AKYA No securities are beneficially owned. 0 16 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 Power of Attorney